"For all cancers, the five-year survival rate more than doubled since the mid-1990s, rising from 17% to 35%. This also signals a 34% drop in cancer mortality since 1991, translating to an estimated 4.8 million fewer cancer deaths between 1991 and 2023. These significant public health advances result from years of public investment in research, early detection and prevention, and improved cancer treatment, according to the report."
""This stunning victory is largely the result of decades of cancer research that provided clinicians with the tools to treat the disease more effectively, turning many cancers from a death sentence into a chronic disease," said Rebecca Siegel, senior scientific director at the American Cancer Society and lead author of the report. As more people survive cancer, there is also a growing focus on the quality of life after treatment. Patients, families and caregivers face physical, financial and emotional challenges."
Seventy percent of Americans diagnosed with cancer can expect to live at least five years, up from 49% in the mid-1970s. Survival gains are strongest for many hard-to-treat cancers: five-year survival for myeloma rose from 32% to 62%; liver cancer from 7% to 22%; late-stage lung cancer from 20% to 37%; melanoma from 16% to 35%; and rectal cancer from 8% to 18%. Overall five-year survival for advanced cancers doubled since the mid-1990s. Cancer mortality declined 34% since 1991, preventing an estimated 4.8 million deaths through 2023. Investment in research, early detection, prevention and improved treatments underpins these advances. Growing survivorship increases attention to post-treatment quality-of-life and related challenges.
Read at Los Angeles Times
Unable to calculate read time
Collection
[
|
...
]